# Beam Therapeutics Inc.: Form 10-K for the period ended Dec 31, 2020

- Company: [Beam Therapeutics Inc.](/companies/beam.md) (CIK 1745999)
- Form: 10-K
- Filed: 2021-03-15
- Accepted by EDGAR: Mar 15, 2021, 17:01 ET
- Period: 2020-12-31
- Accession: 0001564590-21-013190
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1745999/000156459021013190/beam-10k_20201231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1745999/000156459021013190/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 12 months, 2020-01-01 to 2020-12-31 | $103.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2020-01-01 to 2020-12-31 | −$132.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2020-01-01 to 2020-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2020-01-01 to 2020-12-31 | −$194.6m | us-gaap:NetIncomeLoss |
| Operating cash flow | 12 months, 2020-01-01 to 2020-12-31 | −$95.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2020-01-01 to 2020-12-31 | $16.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2020-12-31 | $162.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-12-31 | $308.3m | us-gaap:AssetsCurrent |
| Total assets | at 2020-12-31 | $451.7m | us-gaap:Assets |
| Current liabilities | at 2020-12-31 | $102.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-12-31 | $206.1m | us-gaap:Liabilities |
| Shareholders' equity | at 2020-12-31 | $245.6m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1745999/000156459021013190/beam-10k_20201231.htm

Filed Mar 15, 2021.
Source: SEC EDGAR, the filing index for accession 0001564590-21-013190. Last ingested by Listed: Nov 14, 2026, 12:58 ET. No prices; not investment advice.
